Locus Bioscience
  • Platforms
  • Programs
  • Manufacturing
  • Careers
  • About Us
  • Newsroom
Contact
Media

Press Release

15 Articles found
News Press Releases Locus Insights

Posts pagination

1 2 Next
  • August 12, 2024

    Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases

    Learn More
  • January 23, 2024

    Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy

    Learn More
  • September 13, 2022

    Locus Biosciences Announces First Patient Treated in the ELIMINATE Registrational Phase 2/3 Trial of LBP-EC01 for Urinary Tract Infections

    Learn More
  • May 18, 2022

    Locus Biosciences Announces $35 Million Financing

    Learn More
  • October 19, 2021

    Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital. Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

    Learn More
  • February 24, 2021

    Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy

    Learn More
  • November 10, 2020

    Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections

    Learn More
  • September 30, 2020

    Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ product

    Learn More
  • January 8, 2020

    Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

    Learn More
  • January 3, 2019

    Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

    Learn More

Posts pagination

1 2 Next

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.

Join Our Team

Media Inquiries


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Immunologic Diseases

Home

Platform

Programs

Manufacturing

Careers

About Us

Newsroom

Contact Us

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2025 Locus Biosciences, Inc. All rights reserved.

powered by wildfire